Artificial Intelligence

Daily Journal Corp's revenue soars 25% on the back of its tech arm, revealing a successful pivot and a unique model blending software and investments.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

XA Investments is launching a new index for credit interval funds, a move set to demystify a booming but opaque market for investors and asset managers.

Millions miss their IELTS goals by a tiny margin. A new wave of AI tools promises instant feedback to help save dreams, deadlines, and thousands of dollars.

A new report details how interconnected apps, wearables, and AI are creating a 'Human Performance Economy' that extends far beyond the gym's walls.

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

With promising survival data and a pivotal Phase 3 trial underway, Imunon's localized immunotherapy could finally change the game for ovarian cancer.

CES 2026 will see the debut of the xLean TR1, a robot vacuum that transforms into a handheld and claims to learn like a human. Is this the future?

Arizona State University just crossed $1 billion in research spending. This is the story of its disruptive rise and what it means for health, defense, and AI.

Two physical security leaders, Brivo and Eagle Eye Networks, have merged, creating a cloud and AI powerhouse set to redefine the industry. Here's what it means.

LA Times Studios and Monks are ditching the trade show floor model for an exclusive lounge at CES 2026, signaling a major shift in B2B engagement.

Toobit's futures platform adds 8-chart layouts and 18 chart types, a strategic move reflecting the crypto derivatives market's race for pro-level tools.

AONDevices and Realtek partner on an ultra-low-power platform, promising voice remotes with endless battery life and on-device, personalized AI.

E-commerce firm iPower has invested its cash reserves into Bitcoin and Ethereum, a bold move that analysts see as both a risky gamble and a strategic pivot.

WORK Medical's RMB 10M deal for its AI blood analyzer in East China signals a major push. Its unique 'interpretable AI' may be the key to success.

Biotech pioneer Dr. Patrick Soon-Shiong is named a top influencer in oncology, boosting ImmunityBio amid strong sales and a promising drug pipeline.

Verizon's Q4 report will reveal if its FWA growth can offset mobile pressures and prove the new CEO's strategy is paying off for investors and customers.